Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042

Henry Koon(Case Western Reserve University), Ariela Noy(Memorial Sloan Kettering Cancer Center), Erin Reid(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Zhenghe Wang(Georgetown University), Suthee Rapisuwon(Georgetown University), Michelle A. Rudek(Dana-Farber Cancer Institute), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Jeannette Y. Lee(University of Arkansas at Little Rock), David M. Aboulafia(Virginia Mason Medical Center), Kord Honda(Georgetown University), Bruce J. Dezube(Xilio Therapeutics (United States))
Journal of Clinical Oncology
December 31, 2013
10.1200/jco.2012.48.6365
Cited by 110

Related Papers

Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2018|733
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.
|Journal of Clinical Oncology|1989|483
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model
|Blood|2001|427
Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's Sarcoma
|New England Journal of Medicine|1983|358